BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10090921)

  • 21. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies.
    Triplett DA
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):726-30. PubMed ID: 16258476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiprothombin antibodies and the diagnosis of antiphospholipid syndrome.
    Amengual O; Atsumi T; Koike T
    Clin Immunol; 2004 Aug; 112(2):144-9. PubMed ID: 15240157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of lupus anticoagulant, anticardiolipin, anti-beta2-GPI and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome.
    D'Angelo A; Safa O; Crippa L; Garlando A; Sabbadini MG; Vigano' D'Angelo S
    Thromb Haemost; 1997 Aug; 78(2):967-8. PubMed ID: 9268210
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Many faces of lupus anticoagulants.
    Triplett DA
    Lupus; 1998; 7 Suppl 2():S18-22. PubMed ID: 9814666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β₂ glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies.
    Hirakawa E; Saito K; Hirata S; Atsumi T; Koike T; Tanaka Y
    Mod Rheumatol; 2012 Sep; 22(5):769-73. PubMed ID: 22124547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.
    Galli M; Luciani D; Bertolini G; Barbui T
    Blood; 2003 Mar; 101(5):1827-32. PubMed ID: 12393574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypoprothrombinemia--lupus anticoagulant syndrome].
    Campos MM; Reis Santos I
    Acta Med Port; 2011 Dec; 24 Suppl 3():611-6. PubMed ID: 22856397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients.
    Formiga F; Mitjavila F; Pac M; Moga I
    Lupus; 1997; 6(5):486. PubMed ID: 9229372
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Tàssies D; Font J; Reverter JC; Cervera R; Sánchez-Tapias JM; Mazzara R; Ordinas A; Ingelmo M
    J Hepatol; 1999 May; 30(5):770-3. PubMed ID: 10365800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein κ-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody.
    Hara Y; Makita M; Ishikawa T; Saeki K; Yamamoto K; Imajo K; Shima M; Ieko M
    Ann Hematol; 2013 Apr; 92(4):563-4. PubMed ID: 23076754
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
    Romicka AM; Gazda A; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
    [No Abstract]   [Full Text] [Related]  

  • 38. The relationship between the lupus anticoagulant, anticardiolipin antibodies and antiphospholipid antibodies.
    Tomer Y; Shoenfeld Y
    Isr J Med Sci; 1992 Jan; 28(1):38-40. PubMed ID: 1733897
    [No Abstract]   [Full Text] [Related]  

  • 39. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance].
    Wisløff F; Sletnes KE; Schjetlein R
    Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision medicine and the antiphospholipid syndrome: what is the future?
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Clin Rheumatol; 2020 Apr; 39(4):1015-1017. PubMed ID: 32060811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.